A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 (vol 47, pg 95, 2019)

Gomez Mario; Seybold Ulrich; Roider Julia; Haerter Georg; Bogner Johannes R.

首页> 外文期刊>Infection >A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 (vol 47, pg 95, 2019)

【24h】

A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 (vol 47, pg 95, 2019)

机译：从替诺福韦解毒富马酸核（TDF）转换的艾滋病毒阳性患者重量变化的回顾性分析 - 2015-2017在一家德国大学医院的Tenofovir Alafenide富马酸骨液（TAF）治疗方案（Vol 47，PG 95,2019 的）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The original version of this article unfortunately contained mistakes.

机译：本文的原始版本不幸包含错误。

著录项

来源
《Infection》 |2019年第1期|共2页
作者
Gomez Mario; Seybold Ulrich; Roider Julia; Haerter Georg; Bogner Johannes R.;
展开▼
作者单位

Ludwig Maximilians Univ Munchen Klinikum Univ Sekt Klin Infektiol Med Klin &

Poliklin 4;

Ludwig Maximilians Univ Munchen Klinikum Univ Sekt Klin Infektiol Med Klin &

Poliklin 4;

Ludwig Maximilians Univ Munchen Klinikum Univ Sekt Klin Infektiol Med Klin &

Poliklin 4;

Medicover Ulm MVZ Munsterpl 6 D-89073 Ulm Germany;

Ludwig Maximilians Univ Munchen Klinikum Univ Sekt Klin Infektiol Med Klin &

Poliklin 4;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献

1. A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 (vol 47, pg 95, 2019) [J] . Gomez Mario, Seybold Ulrich, Roider Julia, Infection . 2019,第1期

机译：从替诺福韦解毒富马酸核（TDF）转换的艾滋病毒阳性患者重量变化的回顾性分析 - 2015-2017在一家德国大学医院的Tenofovir Alafenide富马酸骨液（TAF）治疗方案（Vol 47，PG 95,2019 的）
2. Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB) [J] . Pan Calvin Q., Brunetto Maurizia R., Hui Aric Josun, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：从替诺福韦毒性富马酸核（TDF）转向替诺福韦·阿拉芬酰胺（TAF）后1年改善骨骼和肾脏安全性：结果来自2阶段3研究的HBEAG阳性和HBEAG阴性慢性乙型肝炎（CHB）的研究结果
3. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 [J] . Eron Joseph J., Orkin Chloe, Cunningham Douglas, Antiviral Research . 2019,第期

机译：第9周的疗效和安全结果3阶段，随机祖母绿试验评估从增强蛋白酶抑制剂的切换加上Emtricitabine / Tenofovir Disoproxil富马酸莫霉素治疗达伦韦/钴/ Emtricitabine / Tenofovir Alafenaine的单片体方案（D / C / F / TAF）在治疗经验丰富的病毒学 - 被抑制的成年人与HIV-1一起生活
4. Week 48 Results of EMERALD: A Phase 3 Randomized Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (QD) Single-tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed HIV-1-infected Adults [O] . Chloe Orkin, Jean-Michel Molina, Joel Gallant, 2017

机译：EMERALD的第48周结果：第3阶段的非劣效性研究评估了从加强蛋白酶抑制剂（bPI）加恩曲他滨（FTC）/替诺福韦富马酸替诺福韦酯（TDF）转换为每日一次（QD）的功效和安全性）在病毒学上被抑制感染了HIV-1的成年人中Darunavir / Cobicistat / Emtricitabine / Tenofovir Alafenamide（D / C / F / TAF）的单片治疗方案（STR）
5. Correction to: A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017 [O] . Mario Gomez, Ulrich Seybold, Julia Roider, 2018

机译：矫正：从替诺福韦富马酸薄荷（TDF）转换的艾滋病毒阳性患者重量变化的回顾性分析 - 到2015 - 2017年一家德国大学医院的替诺夫罗昔芬酰胺富马酸盐（TAF）治疗方案

A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017 (vol 47, pg 95, 2019)

摘要

著录项

相似文献

相关主题

期刊订阅